Screpanti V - Search Results

1

NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy.

Hayakawa Y, Screpanti V, Yagita H, Grandien A, Ljunggren HG, Smyth MJ, Chambers BJ. Hayakawa Y, et al. Among authors: screpanti v. J Immunol. 2004 Jan 1;172(1):123-9. doi: 10.4049/jimmunol.172.1.123. J Immunol. 2004. PMID: 14688317

2

A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells.

Screpanti V, Wallin RP, Ljunggren HG, Grandien A. Screpanti V, et al. J Immunol. 2001 Aug 15;167(4):2068-73. doi: 10.4049/jimmunol.167.4.2068. J Immunol. 2001. PMID: 11489989

3

Regulation of perforin-independent NK cell-mediated cytotoxicity.

Wallin RP, Screpanti V, Michaëlsson J, Grandien A, Ljunggren HG. Wallin RP, et al. Among authors: screpanti v. Eur J Immunol. 2003 Oct;33(10):2727-35. doi: 10.1002/eji.200324070. Eur J Immunol. 2003. PMID: 14515256 Free article.

4

Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells.

Screpanti V, Wallin RP, Grandien A, Ljunggren HG. Screpanti V, et al. Mol Immunol. 2005 Feb;42(4):495-9. doi: 10.1016/j.molimm.2004.07.033. Mol Immunol. 2005. PMID: 15607805 Review.

5

CD4+ T cells kill Id+ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo.

Lundin KU, Screpanti V, Omholt H, Hofgaard PO, Yagita H, Grandien A, Bogen B. Lundin KU, et al. Among authors: screpanti v. Cancer Immunol Immunother. 2004 Dec;53(12):1135-45. doi: 10.1007/s00262-004-0538-4. Cancer Immunol Immunother. 2004. PMID: 15696611 Free PMC article.

6

The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors.

Djerbi M, Screpanti V, Catrina AI, Bogen B, Biberfeld P, Grandien A. Djerbi M, et al. Among authors: screpanti v. J Exp Med. 1999 Oct 4;190(7):1025-32. doi: 10.1084/jem.190.7.1025. J Exp Med. 1999. PMID: 10510092 Free PMC article.

7

Leukemia inhibitor factor (LIF) inhibits HIV-1 replication via restriction of stat 3 activation.

Tjernlund A, Walther-Jallow L, Behbahani H, Screpanti V, Nowak P, Grandien A, Andersson J, Patterson BK. Tjernlund A, et al. Among authors: screpanti v. AIDS Res Hum Retroviruses. 2007 Mar;23(3):398-406. doi: 10.1089/aid.2006.0100. AIDS Res Hum Retroviruses. 2007. PMID: 17411373

8

Neonatal pattern of V(H) gene utilization in nonobese diabetic mice does not correlate with development of insulitis.

Rietz C, Screpanti V, Brenden N, Fernández C. Rietz C, et al. Among authors: screpanti v. Scand J Immunol. 2001 Nov;54(5):470-6. doi: 10.1046/j.1365-3083.2001.00991.x. Scand J Immunol. 2001. PMID: 11696198 Free article.

9

Overexpression of bcl-2 in T cells affects insulitis in the nonobese diabetic mouse.

Rietz C, Screpanti V, Brenden N, Böhme J, Fernández C. Rietz C, et al. Among authors: screpanti v. Scand J Immunol. 2003 Apr;57(4):342-9. doi: 10.1046/j.1365-3083.2003.01244.x. Scand J Immunol. 2003. PMID: 12662297 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters